FDA UDI
In Commercial Distribution
🇺🇸 United States
CVS Health
DI: 00050428368121
·
Model: 346468
·
WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
Product Codes
11
GMDN Terms
13
Identifiers
1
Pkg Device Count
1
Basic Information
- Brand Name
- CVS Health
- Primary DI
- 00050428368121
- Version / Model
- 346468
- Company Name
- WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
- Labeler DUNS
- 062312574
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2023-08-23
- Public Version
- 1
- Public Version Date
- 2023-08-31
- Public Version Status
- New
- Public Device Record Key
- 8dcdb5c1-6b47-4cac-93de-b5fd4d0da6bb
Device Description
14 Drugs Test Kit - Marijuana (THC50), Cocaine (COC300), Methamphetamine (MET1000), Phencyclidine (PCP25), Opiates (OPI2000), Amphetamine (AMP1000), Ecstasy (MDMA500), Tricyclic Antidepressants (TCA1000), Barbiturates (BAR300), Benzodiazepines (BZO300), Methadone (MTD300), Oxycodone (OXY300), Propoxyphene (PPX300), Buprenorphine (BUP10)
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- No
- Over the Counter (OTC)
- Yes
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| NGG | Test, Methamphetamine, Over The Counter | Clinical Toxicology | 862.3610 | 2 |
| NFY | Test, Cocaine And Cocaine Metabolites, Over The Counter | Clinical Toxicology | 862.3250 | 2 |
| NFW | Test, Cannabinoid, Over The Counter | Clinical Toxicology | 862.3870 | 2 |
| NGM | Test, Phencyclidine (Pcp), Over The Counter | Unknown | U | |
| NGL | Test, Opiates, Over The Counter | Clinical Toxicology | 862.3650 | 2 |
| NFT | Test, Amphetamine, Over The Counter | Clinical Toxicology | 862.3100 | 2 |
| QAW | Test, Tricyclic Antidepressants, Over The Counter | Clinical Toxicology | 862.3910 | 2 |
| PTG | Test, Methadone, Over The Counter | Clinical Toxicology | 862.3620 | 2 |
| QBF | Test, Propoxyphene, Over The Counter | Clinical Toxicology | 862.3700 | 2 |
| PTH | Test, Barbiturate, Over The Counter | Clinical Toxicology | 862.3150 | 2 |
| NFV | Test, Benzodiazepine, Over The Counter | Clinical Toxicology | 862.3170 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 55489 | Amphetamine/methamphetamine group IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs belonging to the amphetamine and/or methamphetamine group(s) [e.g., 3,4-methylenedioxymethamphetamine (MDMA), also known as ecstasy] in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 55712 | Nortriptyline IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of nortriptyline in a clinical specimen. | No | Active |
| 55570 | Cocaine/cocaine metabolite IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of cocaine and/or cocaine metabolites in a clinical specimen. | No | Active |
| 55553 | Cannabinoid/cannabinoid metabolite IVD, reagent | A substance or reactant intended to be used together with other IVDs to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of cannabinoids and/or cannabinoid metabolites (i.e., natural, synthetic) in a clinical specimen. | No | Active |
| 55501 | Methamphetamine-specific IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of a specific methamphetamine in a clinical specimen. | No | Active |
| 55749 | Phencyclidine (PCP) IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of phencyclidine (PCP) in a clinical specimen. | No | Active |
| 30517 | Barbiturate IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of barbiturates in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 55724 | Opiate/opiate metabolite IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of opiate and/or opiate metabolites in a clinical specimen. | No | Active |
| 65385 | Buprenorphine IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of buprenorphine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 55528 | Benzodiazepine group IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of one or multiple benzodiazepines in a clinical specimen. | No | Active |
| 62324 | Propoxyphene/propoxyphene metabolite IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of propoxyphene/propoxyphene metabolites in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 55689 | Methadone IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of methadone in a clinical specimen. | No | Active |
| 55738 | Oxycodone IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of oxycodone in a clinical specimen. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 00050428368121 | GS1 |